| Titre | Auteur | Clics |
|---|
| Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation | WFSBP | 665 |
| Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects | WFSBP | 593 |
| Guidelines for the treatment of adolescent sexual offenders with paraphilic disorders - 2016 | WFSBP | 636 |
| WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry - 2010 | WFSBP | 627 |
| Guidelines for Biological Treatment of Schizophrenia, Part 1 Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance | WFSBP | 585 |
| Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder | WFSBP | 607 |
| Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015 | WFSBP | 548 |
| Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders - 2013 | WFSBP | 538 |
| Guidelines for the pharmacological treatment of anxiety disorders, obsessive – compulsive disorder and post-traumatic stress disorder in primary care - 2012 | WFSBP | 550 |
| Guidelines for Biological Treatment of Personality Disorders - 2007 | WFSBP | 658 |
| Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence - 2011 | WFSBP | 606 |
| Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care - 2007 | WFSBP | 612 |
| Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism - 2008 | WFSBP | 623 |
| Guidelines for the Pharmacological Treatment of Eating Disorders - Juin 2011 | WFSBP | 620 |
| Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance | WFSBP | 1370 |
| Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder | WFSBP | 1279 |
| Pharmacological treatment of anxiety disorders | British Association for Psychopharmacology | 1496 |
| management of attention-deficit/hyperactivity disorder in adolescents in transition to adult service | British Association for Psychopharmacology | 1311 |
| Treating depressive disorders with antidepressants: a revision of the 2000 | British Association for Psychopharmacology | 1204 |
| Evidence-based Guidelines for Treating Bipolar Disorder | British Association for Psychopharmacology | 1243 |
| Evidence-based guidelines for the pharmacological treatment of schizophrenia | British Association for Psychopharmacology | 1163 |
| consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disord | British Association for Psychopharmacology | 1240 |
| Evidence based guidelines for the pharmacological management of substance abuse, harmful use, addict | British Association for Psychopharmacology | 1178 |
| Trouble panique | American Psychiatry Association | 1512 |
| Trouble obsessionnel compulsif | American Psychiatry Association | 1407 |
| Episode dépressif majeur | American Psychiatry Association | 1481 |
| Traitement pharmacologique des troubles anxieux | World Federation of Societies of Biological Psychiatry | 1363 |
| Traitement biologique de l'abus de substances et des troubles relatifs à cet abus | World Federation of Societies of Biological Psychiatry | 1528 |
| Recommandations sur les marqueurs bilogiques dans la dépression | American Psychiatry Association | 1371 |
